BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28991531)

  • 1. Identification of human cytochrome P450 and UGT enzymes involved in the metabolism of ferulic acid, a major bioactive component in traditional Chinese medicines.
    Zhuang XM; Chen L; Tan Y; Yang HY; Lu C; Gao Y; Li H
    Chin J Nat Med; 2017 Sep; 15(9):695-702. PubMed ID: 28991531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes from five liver donors.
    den Braver-Sewradj SP; den Braver MW; Baze A; Decorde J; Fonsi M; Bachellier P; Vermeulen NPE; Commandeur JNM; Richert L; Vos JC
    Eur J Pharm Sci; 2017 Nov; 109():96-110. PubMed ID: 28778465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of metabolic kinetics and reaction phenotyping of ligustrazin by using liver microsomes and recombinant human enzymes].
    Tan Y; Zhuang XM; Shen GL; Li H; Gao Y
    Yao Xue Xue Bao; 2014 Mar; 49(3):374-9. PubMed ID: 24961110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic interactions of rosmarinic acid with human cytochrome P450 monooxygenases and uridine diphosphate glucuronosyltransferases.
    Kim SB; Kim KS; Kim DD; Yoon IS
    Biomed Pharmacother; 2019 Feb; 110():111-117. PubMed ID: 30466000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro metabolism of the anti-inflammatory clerodane diterpenoid polyandric acid A and its hydrolysis product by human liver microsomes and recombinant cytochrome P450 and UDP-glucuronosyltransferase enzymes.
    Bendikov MY; Miners JO; Simpson BS; Elliot DJ; Semple SJ; Claudie DJ; McKinnon RA; Gillam EMJ; Sykes MJ
    Xenobiotica; 2017 Jun; 47(6):461-469. PubMed ID: 27412850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Charactering the metabolism of cryptotanshinone by human P450 enzymes and uridine diphosphate glucuronosyltransferases in vitro.
    Zeng J; Fan YJ; Tan B; Su HZ; Li Y; Zhang LL; Jiang J; Qiu FR
    Acta Pharmacol Sin; 2018 Aug; 39(8):1393-1404. PubMed ID: 29417949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isochlorogenic acid A affects P450 and UGT enzymes in vitro and in vivo.
    Wang J; Wang H; Peng Y; Wang GJ; Hao HP
    Chin J Nat Med; 2016 Nov; 14(11):865-870. PubMed ID: 27914530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiol.
    Usmani KA; Hodgson E; Rose RL
    Chem Biol Interact; 2004 Dec; 150(3):221-32. PubMed ID: 15560889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the in vitro metabolism of psoralidin among different species and characterization of its inhibitory effect against UDP- glucuronosyltransferase (UGT) or cytochrome p450 (CYP450) enzymes.
    Shi X; Zhang G; Mackie B; Yang S; Wang J; Shan L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Sep; 1029-1030():145-156. PubMed ID: 27428458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of the anthelmintic drug niclosamide by cytochrome P450 enzymes and UDP-glucuronosyltransferases: metabolite elucidation and main contributions from CYP1A2 and UGT1A1.
    Lu D; Ma Z; Zhang T; Zhang X; Wu B
    Xenobiotica; 2016; 46(1):1-13. PubMed ID: 26068521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of oxycodone in vitro metabolism by human cytochromes P450 and UDP-glucuronosyltransferases.
    Romand S; Spaggiari D; Marsousi N; Samer C; Desmeules J; Daali Y; Rudaz S
    J Pharm Biomed Anal; 2017 Sep; 144():129-137. PubMed ID: 27692933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro metabolism of jaceosidin and characterization of cytochrome P450 and UDP-glucuronosyltransferase enzymes in human liver microsomes.
    Song WY; Ji HY; Baek NI; Jeong TS; Lee HS
    Arch Pharm Res; 2010 Dec; 33(12):1985-96. PubMed ID: 21191764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro characterization of the human biotransformation and CYP reaction phenotype of ET-743 (Yondelis, Trabectidin), a novel marine anti-cancer drug.
    Brandon EF; Sparidans RW; Guijt KJ; Löwenthal S; Meijerman I; Beijnen JH; Schellens JH
    Invest New Drugs; 2006 Jan; 24(1):3-14. PubMed ID: 16379042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics.
    Gröer C; Busch D; Patrzyk M; Beyer K; Busemann A; Heidecke CD; Drozdzik M; Siegmund W; Oswald S
    J Pharm Biomed Anal; 2014 Nov; 100():393-401. PubMed ID: 25218440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolic detoxification of bakuchiol is mediated by cytochrome P450 enzymes in human liver microsomes].
    Li AF; Shen GL; Jiao SY; Li H; Wang Q
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Jun; 44(3):431-6. PubMed ID: 22692316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450-mediated metabolism of triclosan attenuates its cytotoxicity in hepatic cells.
    Wu Y; Chitranshi P; Loukotková L; Gamboa da Costa G; Beland FA; Zhang J; Fang JL
    Arch Toxicol; 2017 Jun; 91(6):2405-2423. PubMed ID: 27896399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Saccharolactone on CYP-mediated Metabolism of Xenobiotics.
    Behera D; Jain P; Kurawattimath V; Gowda N
    Drug Metab Bioanal Lett; 2023; 16(2):121-132. PubMed ID: 37612873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro identification of human cytochrome P450 isoforms involved in the metabolism of Geissoschizine methyl ether, an active component of the traditional Japanese medicine Yokukansan.
    Matsumoto T; Kushida H; Maruyama T; Nishimura H; Watanabe J; Maemura K; Kase Y
    Xenobiotica; 2016; 46(4):325-34. PubMed ID: 26337900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro characterization of the metabolic pathways and cytochrome P450 inhibition and induction potential of BMS-690514, an ErbB/vascular endothelial growth factor receptor inhibitor.
    Hong H; Su H; Ma L; Yao M; Iyer RA; Humphreys WG; Christopher LJ
    Drug Metab Dispos; 2011 Sep; 39(9):1658-67. PubMed ID: 21673131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolite Profiling and Reaction Phenotyping for the
    Yadav AS; Shah NR; Carlson TJ; Driscoll JP
    Chem Res Toxicol; 2020 Jan; 33(1):249-257. PubMed ID: 31815452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.